Image used for representational purpose only. 
Health

Late dinners may increase the risk of breast and prostate cancer: Research

Compared with individuals, sleeping immediately after supper, those sleeping two or more hours after supper had a 20 per cent reduction in cancer risk for breast and prostate cancer

From our online archive

WASHINGTON: Late dinners could increase the risk of breast and prostate cancer, finds a new research.

The study included 621 cases of prostate and 1205 of breast cancer with 872 male and 1321 female population controls. Participants were interviewed on the timing of meals and sleep, and they completed a Food Frequency Questionnaire.

Compared with individuals, sleeping immediately after supper, those sleeping two or more hours after supper had a 20 per cent reduction in cancer risk for breast and prostate cancer combined and in each cancer individually.

A similar protection was observed in individuals having supper before 9 pm compared with supper after 10 pm.

The findings stress the importance of evaluating the body's internal clock--or circadian rhythms--in studies on diet and cancer, and the need to develop dietary recommendations for cancer prevention that focus not only on type and quantity of food intake.

"If the findings are confirmed, they will have implications for cancer prevention recommendations that currently do not take meal timing into account," said lead author Dr Manolis Kogevinas. "The impact could be especially important in cultures such as those of southern Europe where people tend to have supper late."

The study has been published in the International Journal of Cancer. 

CBI arrests NTA biology expert; second paper-setting panel member detained in NEET paper leak probe

India's aspirations no longer limited to its borders: PM Modi tells diaspora at The Hague

'Why doesn't the PM work from home?' Punjab CM slams Modi's foreign visits amid austerity call

West Bengal government dissolves Police Welfare Board, says it worked as one party's 'frontal organisation'

NCB for the first time in India seizes Captagon drug worth Rs 182 crore

SCROLL FOR NEXT